The cluster is too small relative to market cap to signal material concern. Monitor for any C-suite selling or a material increase in dollar volume above 0.1% of market cap. The next quarterly filing (10-Q) will provide the best read on business momentum.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 18 $55.63entry
- T+1 · 3mo ago +11.79%α +11.58% · $62.19
- T+5 · 3mo ago +16.34%α +16.54% · $64.72
- T+20 · 2mo ago +30.65%α +32.40% · $72.68
- T+60 · 6d ago +13.07%α +15.11% · $62.90
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two 10x Genomics directors sold a combined $1.28M in open-market transactions over a 7-day window. Director Stuelpnagel sold $979K at ~$57.58 and Director Teichmann sold $302K at ~$57.29. While the cluster is notable for involving two directors, the total value is only ~0.018% of TXG's $7.3B market cap, well below the 0.1% materiality threshold, making this routine portfolio diversification rather than a bearish signal.
Key Financial Metrics
Key Facts
- Two directors sold a combined $1.28M in open-market sales over 7 days
- Director John R. Stuelpnagel sold 17,000 shares at ~$57.58 for $979K on 2026-08-11
- Director Sarah A. Teichmann sold 5,278 shares at ~$57.29 for $302K on 2026-08-13
- Total sales represent ~0.018% of TXG's $7.3B market cap, well below the 0.1% materiality threshold
- No C-suite executives participated in the cluster; both sellers are directors
- Recent 30-day insider activity shows $1.6M in total sells, consistent with routine patterns
Financial Impact
$1.28M in director open-market sales, representing ~0.018% of market cap
Risk Factors
- Insider selling could accelerate if business fundamentals deteriorate
- Directors selling near $57 may signal a perceived fair-value ceiling
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TXG-1787034317935 |
Track record
28 reports on TXG
1 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $58.19 +5.04% settles Feb 12
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $58.19 −10.55% settles Feb 5
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $58.19 −10.55% settles Feb 5
- Nov 5, 202611d ago 8-K Bullish 6/10 No price data
- Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $58.19 −1.84% settles Feb 4
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $65.29 Now $58.19 −10.87% settles Feb 1
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $58.19 −18.67% settles Jan 21
- Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $58.19 −24.70% settles Jan 5
- Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $58.19 −32.11% settles Dec 21
- Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $58.19 −23.05% settles Dec 17
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers